Drug intelligence / Profile preview

Beta-Hydroxyleucine

Development stage
Unknown
Modality
Small Molecules
01

Overview

Beta-Hydroxyleucine is an optically active nonprotein alpha-amino acid and an analog of leucine. It functions as a research tool to investigate protein synthesis, processing, and enzyme activity. It has been shown to inhibit serine proteases like bovine trypsin and proteinase K, with competitive inhibition observed for trypsin. As a leucine analog, it can modulate the amino acid-sensitive TOR signaling pathway in adipocytes, stimulating 4E-BP1 phosphorylation. Its incorporation into nascent peptide chains can interfere with various protein processing events, including signal peptide function, dibasic cleavage of prohormones, and oligosaccharide processing, leading to altered protein conformation and secretion. Additionally, it has been implicated in the regulation of alpha-acetohydroxy acid synthetase activity in bacteria.

Other names
(2R,3S)-beta-hydroxyleucine(2S,3R)-beta-hydroxyleucinethreo-L-beta-hydroxyleucinebeta-DL-hydroxyleucine
02

Targets

PRSS1 (Trypsin family)

Beyond the preview

Go deeper on Beta-Hydroxyleucine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-Hydroxyleucine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call